Document is current
Any future updates will be listed below
-
Authors
Dauphinot, Virginie
Calvi, Sylvain
Moutet, Claire
Xie, Jing
Dautricourt, Sophie
Batsavanis, Anthony
Krolak-Salmon, Pierre
Garnier-Crussard, Antoine
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 25 August 2024
First Online: 5 September 2024
Declarations
:
: This study was performed in accordance with the principles of the Declaration of Helsinki. The opinion of the scientific and ethical committee of the Hospices Civils de Lyon was requested, and the favorable opinion was obtained on 12/7/2020. The CLIMER study was classified as a non-interventional research that does not involve the human person (RNIPH), and as such, signed informed consent from patients was not required under the French general regulation for data protection (RGPD). However, individual information has been sent to patients (and their caregivers) to inform them of the use of patient health data in the context of this research. Patients could object to the use of their health data. The data processing of this research was part of the MR-004 reference methodology and as such, the declaration form has been completed. The study is reported on the clinicaltrials registry: .
: Not applicable.
: Virginie Dauphinot, Sylvain Calvi, Claire Moutet, Jing Xie, Sophie Dautricourt, and Anthony Bathsavanis, Antoine Garnier-Crussard are working at the University Hospital of Lyon. Pierre Krolak-Salmon was working at University Hospital of Lyon at the time of the study. At the time of the study, and independent of this work, AGC, JX and SD are unpaid sub-investigators or principal investigator in NCT04867616 (UCB Pharma), NCT04241068 (Biogen), NCT05310071 (Biogen), NCT03446001 (TauRx Therapeutics), NCT03444870 (Roche), NCT04374253 (Roche), NCT04777396 (Novo Nordisk), NCT04777409 (Novo Nordisk), NCT04770220 (Alzheon), NCT05423522 (Medesis Pharma).Independent of this work, PKS was an unpaid sub-investigator or principal investigator in NCT04867616 (UCB Pharma), NCT04241068 (Biogen), NCT03446001 (TauRx Therapeutics), NCT03444870 (Roche), NCT04374253 (Roche), NCT04777396 (Novo Nordisk), NCT04777409 (Novo Nordisk), NCT04770220 (Alzheon), NCT05423522 (Medesis Pharma), and provides consultancy for Biogen, Roche, Novartis, MSD, Lilly, Pfizer, Abbvie.
